Compare Illumina, Inc. (ILMN) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Remitly Global Inc — how do they compare? Illumina, Inc. trades at $189.49 (market cap $27.94B), while Remitly Global Inc trades at $23.78 (market cap $5.02B). The key difference: Illumina, Inc. is far larger — about 5.6× Remitly Global Inc's market cap. Which is the better fit depends on your goals.
| ILMN | RELY | |
|---|---|---|
Market Cap | $27.94B | $5.02B |
Sector | Health | Technology |
52-Week High | $194.33 | $25.23 |
52-Week Low | $91.00 | $12.20 |
Enterprise Value | $29.33B | $4.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
RELY trades at $23.84, down 1.2% on the day, with a bullish technical signal from moving averages and strong analyst consensus. The company shows accelerating revenue growth, reaching $1.64 billion in 2025, and achieved profitability with net income of $67.93 million. Recent news highlights expansion into the UAE market and positive earnings beats.
The outlook is positive, driven by market share gains in the remittance sector and raised 2026 guidance. Key risks include intense competition and execution challenges in international expansion. Wall Street sentiment is strongly bullish with a $27.40 price target, suggesting 15% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
